CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 8-K Event Material agreement · Acquisition or sale completed · Exit or restructuring costs
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results · Other events
- 8-K Event Material agreement · Other events
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Exit or restructuring costs · Executive or director change
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
Page 5 of 14 · 269 filings